Theorem Clinical Research, the US-based provider of clinical research and development services, has formed a strategic alliance with Decision Driver Analytics to bring more health economics and outcomes research (HEOR) insights into product development.

Founded by president Elizabeth Brooks in 2006 and operating out of Asheville, North Carolina, Decision Driver Analysis (DDA) offers drug and medical device companies a range of real-time research and analytical services to help optimise value at all stages of the development process and throughout the product lifecycle.

Under the alliance with Theorem, the two companies will integrate HEOR, predictive modelling and definitive analysis into research programmes for pharmaceuticals and medical devices. The aim is to maximise returns on R&D investment and ensure successful outcomes both from a regulatory and marketing perspective.

Brooks has designed numerous health-economics models and market-development programmes, Theorem pointed out.

Backed by a team of specialists including health economists, epidemiologists, biostatisticians, medical writers and reimbursement experts, the DDA president “is known for an ability to make statistical results understandable and actionable”, it added.

Right answers

“Knowing the right answers to key questions at critical decision points in the development process can make the difference between having the latest blockbuster or an expensive failure,” commented John Potthoff, president and chief executive officer of Theorem Clinical Research.

“Decision Driver Analytics’ product lifecycle value analysis and exceptional economic insight help clients make high-value decisions with confidence throughout the entire development process.”